240 related articles for article (PubMed ID: 32613705)
1. Periodically Ordered, Nuclease-Resistant DNA Nanowires Decorated with Cell-Specific Aptamers as Selective Theranostic Agents.
Xue C; Zhang S; Yu X; Hu S; Lu Y; Wu ZS
Angew Chem Int Ed Engl; 2020 Sep; 59(40):17540-17547. PubMed ID: 32613705
[TBL] [Abstract][Full Text] [Related]
2. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Li N; Xiang MH; Liu JW; Tang H; Jiang JH
Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
[TBL] [Abstract][Full Text] [Related]
3. A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy.
Du X; Li L; Wei S; Wang S; Li Y
J Mater Chem B; 2020 Feb; 8(8):1660-1671. PubMed ID: 32011619
[TBL] [Abstract][Full Text] [Related]
4. Aptamer CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranostics.
Zhou C; Chen T; Wu C; Zhu G; Qiu L; Cui C; Hou W; Tan W
Chem Asian J; 2015 Jan; 10(1):166-71. PubMed ID: 25377905
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Albumin-Based Delivery System Generated by Programmed Assembly for Tumor-Targeted Multimodal Therapy and Imaging.
Xu L; Wang SB; Xu C; Han D; Ren XH; Zhang XZ; Cheng SX
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38385-38394. PubMed ID: 31556589
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
8. Cell Membrane Capsules for Encapsulation of Chemotherapeutic and Cancer Cell Targeting in Vivo.
Peng LH; Zhang YH; Han LJ; Zhang CZ; Wu JH; Wang XR; Gao JQ; Mao ZW
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18628-37. PubMed ID: 26262951
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of DNA Framework-Encapsulated Native Therapeutic Protein into Cancer Cells.
Li D; Li X; Yang F; Yuan R; Xiang Y
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54489-54496. PubMed ID: 33253532
[TBL] [Abstract][Full Text] [Related]
10. Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging.
Chen T; Shukoor MI; Wang R; Zhao Z; Yuan Q; Bamrungsap S; Xiong X; Tan W
ACS Nano; 2011 Oct; 5(10):7866-73. PubMed ID: 21888350
[TBL] [Abstract][Full Text] [Related]
11. Programmable Self-Assembly of Protein-Scaffolded DNA Nanohydrogels for Tumor-Targeted Imaging and Therapy.
Li N; Wang XY; Xiang MH; Liu JW; Yu RQ; Jiang JH
Anal Chem; 2019 Feb; 91(4):2610-2614. PubMed ID: 30701962
[TBL] [Abstract][Full Text] [Related]
12. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
13. Bead-String-Shaped DNA Nanowires with Intrinsic Structural Advantages and Their Potential for Biomedical Applications.
Gao Y; Li Q; Zhang J; Wu C; Shen Z; Xue C; Chang HT; Wu ZS
ACS Appl Mater Interfaces; 2020 Jan; 12(3):3341-3353. PubMed ID: 31878778
[TBL] [Abstract][Full Text] [Related]
14. Proof of concept for inhibiting metastasis: circulating tumor cell-triggered localized release of anticancer agent via a structure-switching aptamer.
Chen N; Yang X; Wang Q; Jian L; Shi H; Qin S; Wang K; Huang J; Liu W
Chem Commun (Camb); 2016 May; 52(41):6789-92. PubMed ID: 27121864
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
[TBL] [Abstract][Full Text] [Related]
16. In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.
Si H; Wang L; Li Q; Li X; Li L; Tang B
Chem Commun (Camb); 2018 Jul; 54(59):8277-8280. PubMed ID: 29989641
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
18. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
19. Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy.
Zhu L; Yang J; Ma Y; Zhu X; Zhang C
J Am Chem Soc; 2022 Feb; 144(4):1493-1497. PubMed ID: 35073490
[TBL] [Abstract][Full Text] [Related]
20. Aptamers in targeted nanotherapy.
Mathew A; Maekawa T; Sakthikumar D
Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
